Research continues to be our best defense against cancer.
It improves survival and quality of life for people around
the world by spurring the development of new and better
ways to prevent, detect, diagnose, treat, and cure some of
the diseases we call cancer.
As the first and largest professional organization in the world
dedicated to advancing every aspect of cancer research, from
basic science to translational research to clinical research
and population science, the American Association for
Cancer Research (AACR) is dedicated to increasing public
understanding of cancer and the importance of cancer
research to public health. It is also committed to advocating
for increased federal funding to government agencies that
fuel progress against cancer, in particular, the National
Institutes of Health (NIH), the National Cancer Institute
(NCI), and the U.S. Food and Drug Administration (FDA).
The annual AACR Cancer Progress Report to Congress
and the American public is a cornerstone of the AACR’s
educational and advocacy efforts. This seventh edition of
the report highlights how research continues to improve
and extend lives, like the lives of the courageous individuals
featured in the report who have shared their experiences
with cancer. It also underscores how unwavering, bipartisan
support from Congress, in the form of robust, sustained,
and predictable increases in funding for the NIH, NCI,
and FDA, is vital if we are to accelerate the pace of progress
against cancer and save more lives from this devastating
collection of diseases.
CANCER IN 2017
Basic research is the foundation of new and better
approaches to cancer prevention, detection, diagnosis,
and treatment, which are driving down overall U.S. cancer
incidence and death rates and increasing the number of
children and adults who are living longer, higher-quality
lives after a cancer diagnosis. In fact, the age-adjusted U.S.
cancer death rate declined by 25 percent from 1991 to 2014,
a reduction that translates into 2. 1 million cancer deaths
avoided. In addition, the U.S. 5-year relative survival rate
for all cancers combined rose from 49 percent in the mid-
1970s to 69 percent in 2013, which is the last year for which
we have data.
“ Since I was in medical school
in the late 1970s, I have seen a
transformation in cancer care.
This change … is a result of
tremendous advances in basic
and applied research. ”
ages 0 to 14
From 2010 to 2014,
overall cancer death rates fell by: